Why the study?
What clinical features distinguish true neuroleptic malignant syndrome from NMS-like acute medical illnesses in patients on neuroleptic medication?
What clinical features distinguish true neuroleptic malignant syndrome from NMS-like acute medical illnesses in patients on neuroleptic medication?
Distinguishing NMS from other acute medical illnesses requires careful clinical evaluation, as features like fever and CK levels may be similar, but specific signs like rigidity, diaphoresis, and cogwheeling are more common in true NMS.
Answers are grounded in this paper and cite their sources.
May aid differentiation via targeted signs in neuroleptic-treated patients; leaves open need for prospective validation before changing diagnostic practice.
A study of 34 hospitalized patients with suspected neuroleptic malignant syndrome (NMS) found that 24 had NMS and the other 10 had acute, usually serious, medical problems. There were no demographic, psychopathologic, or treatment-related differences between the groups. NMS patients had more dehydration, cogwheeling, diaphoresis, disorientation, drooling, dysphagia, and rigidity and higher diastolic blood pressure. The groups had similar fevers, heart rates, creatine kinase levels, and white blood cell counts. Three non-NMS patients died during their acute illnesses. Results suggest that considering NMS as a diagnosis and ruling out other acute illnesses such as pneumonia are equally important when a patient on neuroleptic medication becomes medically ill.
No takes yet. Share an insight, caveat, or question.
Sewell et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: